MichaelD.CaldwellMDPhD, FACS

PubMed

• 52 citations
  Bacteria and Antibiotics in Wound Healing.
  Michael D. Caldwell> ;The Surgical Clinics of North America. 2020 Aug 1
• 18 citations
  Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.
  Elisa Danese, Sara Raimondi, Martina Montagnana, Angela Tagetti, Taimour Y. Langaee, Paola Borgiani, Cinzia Ciccacci, Antonio J. Carcas, Alberto M. Borobia, Hoi Y. Ton...> ;Clinical Pharmacology and Therapeutics. 2019 Jun 1
• 13 citations
  A Machine-Learning-Based Drug Repurposing Approach Using Baseline Regularization.
  Zhaobin Kuang, Yujia Bao, James A. Thomson, Michael D. Caldwell, Peggy L. Peissig, Ron Stewart, Rebecca Willett, David C. Page> ;Methods in Molecular Biology. 2019 Jan 1
• 4 citations
  SNPs Previously Associated with Dupuytren’s Disease Replicated in a North American Cohort
  Eric R. Anderson, Zhan Ye, Michael D. Caldwell, James K. Burmester> ;Clinical Medicine & Research. 2014 Dec 1
• 36 citations
  Relational machine learning for electronic health record-driven phenotyping
  Peggy L. Peissig, Vítor Santos Costa, Michael D. Caldwell, Carla Rottscheit, Richard L. Berg, Eneida A. Mendonça, David C. Page> ;Journal of Biomedical Informatics. 2014 Dec 1
• 528 citations
  A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
  Stephen E. Kimmel, Benjamin French, Scott E. Kasner, Julie A. Johnson, Jeffrey L. Anderson, Brian F. Gage, Yves Rosenberg, Charles S. Eby, Rosemary Madigan, Robert B. ...> ;The New England Journal of Medicine. 2013 Dec 11
• 11 citations
  Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial
  Stephen E. Kimmel, Benjamin French, Jeffrey L. Anderson, Brian F. Gage, Julie A. Johnson, Yves Rosenberg, Nancy L. Geller, Scott E. Kasner, Charles S. Eby, Jungnam Joo...> ;American Heart Journal. 2013 Sep 1
• 12 citations
  Randomized trial of pragmatic education for low-risk COPD patients: impact on hospitalizations and emergency department visits
  Haamid H Siddique, Raymond H Olson, Connie M. Parenti, Thomas S. Rector, Michael Caldwell, Naresh A. Dewan, Kathryn L. Rice> ;International Journal of Chronic Obstructive Pulmonary Disease. 2012 Oct 25
• 8 citations
  Evaluation of a mitochondrial DNA mutation in maternally inherited and sporadic cases of Dupuytren disease.
  Eric R. Anderson, James K. Burmester, Michael D. Caldwell> ;Clinical Medicine & Research. 2012 Aug 1
• 52 citations
  Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy
  Benjamin D. Horne, Petra A. Lenzini, Mia Wadelius, Andrea L. Jorgensen, Stephen E. Kimmel, Paul M. Ridker, Niclas Eriksson, Jeffrey L. Anderson, Munir Pirmohamed, Nita...> ;Thrombosis and Haemostasis. 2011 Dec 21
• 8 citations
  Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses
  James K. Burmester, Richard L. Berg, Ingrid Glurich, Steven H. Yale, John R. Schmelzer, Michael D. Caldwell> ;Clinical Medicine & Research. 2011 Nov 1
• 63 citations
  Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study
  Joanne M. Langley, George Risi, Michael Caldwell, Larry Gilderman, Bruce Berwald, Charles Fogarty, Terry Poling, Dennis Riff, Mira Baron, Louise Frenette, Eric Sheldon...> ;The Journal of Infectious Diseases. 2011 Jun 15
• 90 citations
  A randomized controlled trial of genotype-based Coumadin initiation
  James K. Burmester, Richard L. Berg, Steven H. Yale, Carla Rottscheit, Ingrid Glurich, John R. Schmelzer, Michael D. Caldwell> ;Genetics in Medicine. 2011 Jun 1
• 2 citations
  Wound surgery.
  Michael D Caldwell> ;The Surgical Clinics of North America. 2010 Dec 1
• Wounds and wound management. Preface.
  Michael D. Caldwell> ;The Surgical Clinics of North America. 2010 Dec 1
• 223 citations
  Disease Management Program for Chronic Obstructive Pulmonary Disease A Randomized Controlled Trial
  Kathryn L. Rice, Naresh Dewan, Hanna E. Bloomfield, Joseph Grill, Tamara M. Schult, David B. Nelson, Sarita Kumari, Mel Thomas, Lois J. Geist, Caroline Beaner, Michael...> ;American Journal of Respiratory and Critical Care Medicine. 2010 Oct 1
• 168 citations
  Integration of genetic, clinical, and INR data to refine warfarin dosing.
  Petra A. Lenzini, Mia Wadelius, Stephen E. Kimmel, Jeffrey L. Anderson, Andrea L. Jorgensen, Munir Pirmohamed, Michael D. Caldwell, Nita A. Limdi, James K. Burmester, ...> ;Clinical Pharmacology and Therapeutics. 2010 May 1
• 3 citations
  New adjuvants to enhance anticoagulant activity of Warfarin
  Jeremiah J. Stromich, Ashley K. Weber, Yousef R. Mirzaei, Michael D. Caldwell, David E. Lewis> ;Bioorganic & Medicinal Chemistry Letters. 2010 Mar 15
• 3 citations
  Perioperative genomic profiles using structure-specific oligonucleotide probes.
  Kirk J. Hogan, James K. Burmester, Michael D. Caldwell, Quinn H. Hogan, Douglas B. Coursin, Dawn N. Green, Rebecca R. Selzer, Thomas P. Broderick, Deborah A. Rusy, Mar...> ;Clinical Medicine & Research. 2009 Sep 1
• 21 citations
  Understanding the pharmacogenetic approach to warfarin dosing.
  Ingrid Glurich, James K. Burmester, Michael D. Caldwell> ;Heart Failure Reviews. 2010 May 1
• 28 citations
  The Marshfield Clinic Personalized Medicine Research Project: 2008 scientific update and lessons learned in the first 6 years
  Catherine A. McCarty, Peggy L. Peissig, Michael D. Caldwell, Russell A. Wilke> ;Personalized Medicine. 2008 Sep 9
• 386 citations
  CYP4F2 genetic variant alters required warfarin dose.
  Michael D. Caldwell, Tarif Awad, Julie A. Johnson, Brian F. Gage, Mat Falkowski, Paul Gardina, Jason Hubbard, Yaron Turpaz, Taimour Y. Langaee, Charles S. Eby, Cristi ...> ;Blood. 2008 Apr 15
• 118 citations
  Evaluation of Genetic Factors for Warfarin Dose Prediction
  Michael D. Caldwell, Richard L. Berg, Kai Qi Zhang, Ingrid Glurich, John R. Schmelzer, Steven H. Yale, Humberto Vidaillet, James K. Burmester> ;Clinical Medicine & Research. 2007 Mar 1
• 20 citations
  Necrotizing Fasciitis Due to a Methicillin-Sensitive Staphylococcus aureus Isolate Harboring an Enterotoxin Gene Cluster
  William R. Morgan, Michael D. Caldwell, Jennifer M. Brady, Mary E. Stemper, Kurt D. Reed, Sanjay K. Shukla> ;Journal of Clinical Microbiology. 2007 Feb 1
• 9 citations
  Mactinin treatment promotes wound-healing-associated inflammation in urokinase knockout mice.
  Sharon D Luikart, Brett K. Levay-Young, Tim Hinkel, Jeffry D. Shearer, Charles D. Mills, Michael D. Caldwell, Margaret R. Gyetko, Theodore R. Oegema> ;Wound Repair and Regeneration. 2006 Mar 1
• Join now to see all

Journal Articles

• A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing  
  Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF,Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER III, Fang..., N Engl J Med, 12/12/2013
• Rationale and Design of the Clarification of Optimal Anticoagulation through Genetics (COAG) Trial  
  Kimmel SE, French B, Anderson J, Gage BF, Johnson JA, Rosenberg YD, Geller NL, Kasner S, Eby CS, Joo J, Caldwell MD, Goldhaber SZ, Hart RG, Cifelli D Madigan R, Brens..., American Heart Journal, 9/1/2013
• A Preliminary Investigation into Predictive Models for Adverse Drug Events  
  Davis J, Costa VS, Peissig P, Caldwell MD, Page D, Proceedings of the AAAI-13 Workshop on Expanding the Boundaries of Health Informatics Using AI, 1/1/2013
• Demand-Driven Clustering in Relational Domains for Predicting Adverse Drug Events  
  Davis J, Costa VS, Peissig P, Caldwell M, Berg E, Page D, Proceedings of the International Conference on Machine Leaning, 1/1/2012
• Identifying Adverse Drug Events by Relational Learning Identifying Adverse Drug Events by Relational Learning  
  Page D, Costa VS, Natarajan S, Barnard A, Peissig P Caldwell M, Proceedings of AAAI, 1/1/2012
• Evaluation of a Mitochondrial DNA Mutation in Maternally Inherited and Sporadic Cases of Dupuytren Disease  
  Anderson ER, Burmester JK, Caldwell MD, Clinical Medicine and Research, 1/1/2012
• Demand-Driven Clustering in Relational Domains for Predicting Adverse Drug Events.  
  Davis, J., Costa, V.S., Peissig, P., Caldwell, M., Berg, E., Page, D, Proceedings of the International Conference on Machine Leaning (ICML), 1/1/2012
• Identifying Adverse Drug Events by Relational Learning.  
  Page, D., Costa, V.S., Natarajan, S., Barnard, A., Peissig, P. Caldwell, M, Proceedings of AAAI, 1/1/2012
• Evaluation of a Mitochondrial DNA Mutation in Maternally Inherited and Sporadic Cases of Dupuytren Disease.  
  Anderson, E. R., Burmester, J. K., Caldwell, M. D., Clinical Medicine and Research., 1/1/2012
• Pharmacogenetic Warfarin Dose Refinements Remain Significantly Influenced by Genetic Factors After One Week of Therapy  
  Horne BD, Lenzini PA, Wadelius M, Jorgensen AL, Kimmel SE, Ridker PM, Eriksson N, Anderson JL, Pirmohamed M, Limdi NA, Pendleton RC, McMillin GA, Burmester JK, Kurnik ..., Thrombosis and Haemostasis, 12/21/2011
• Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses.  
  Burmester, JK, Berg, RL, Glurich, I, Yale, SH, Schmelzer, JR, Caldwell, MD., Clinical Medicine and Research, 11/1/2011
• A Randomized-Controlled Trial of Genotype-Based Coumadin Initiation.  
  Burmester, JK, Berg, RL, Yale, SH, Rottscheit, CM, Glurich, IE, Schmelzer, JR, Caldwell, MD, Genetics in Medicine, 6/1/2011
• International Warfarin Pharmacogenetics Consortium Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups  
  Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford DC, Lee MT, Chen CH, Motsinger-Reif A, Sagreiya H, Liu N, Wu AH, Gage BF, Jorgensen A, Pirmohamed M, Shin JG, S..., Blood, 5/6/2010
• Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.  
  Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford DC, Lee MT, Chen CH, Motsinger-Reif A, Sagreiya H, Liu N, Wu AH, Gage BF, Jorgensen A, Pirmohamed M, Shin JG, S..., Blood, 5/1/2010
• New Adjuvants to Enhance Anticoagulant Activity of Warfarin.  
  Stromich, J.J., Weber, A.K., Mirzaei, Y.R., Caldwell, M.D., Lewis, D.E, Bioorganic & Medicinal Chemistry Letters, 1/1/2010
• Understanding The Pharmacogenetic Approach To Warfarin Dosing  
  Glurich, I., Burmester, J., Caldwell, M.D, Heart Failure Reviews, 1/1/2010
• Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing.  
  P Lenzini1, M Wadelius, S Kimmel, JL Anderson, AL Jorgensen, M Pirmohamed, MD Caldwell, N Limdi, JK Burmester, MB Dowd, P Angchaisuksiri, AR Bass, J Chen, N Er..., Clinical Pharmacology and Therapeutics, 1/1/2010
• Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data.  
  The International Warfarin Pharmacogenetic Consortium. Caldwell, M. D. (Member of the Consortium and of the Writing Committee, among other committees), New England Journal of Medicine, 1/1/2009
• Perioperative Genomic Profiles Using Structure-Specific Oligonucleotide Probes  
  Hogan, K.J., Burmester, J.K., Caldwell, M.D., Hogan, Q.H., Coursin, D.B., Green, D.N., Selzer, R.M.R., Broderick, T.P., Rusy, D.A., Poroli, M., Lutz, A.L., Sanders, A...., Clin. Med. Res., 1/1/2009
• CYP4F2 genetic variant alters required warfarin dose.  
  Caldwell, M.D., Awad, T., Johnson, J.A., Gage, B.F., Falkowski, M., Gardina, P., Hubbard, J., Turpaz, Y., Langaee, T.Y., Eby, C., King, C., Brower, A., Schmelzer, J.R...., Blood, 1/1/2008
• Machine Learning for Personalized Medicine: Will This Drug Give Me a Heart Attack?, In the Proceedings of Machine Learning in Health Care Applications Workshop In conj...  
  Davis J, Lantz E, Page D, Struyf J, Peissig P, Vidailet H, Caldwell MD, Health Workshop, 1/1/2008
• The Marshfield Clinic Personalized Medicine Research Project: 2008 scientific update and lessons learned in the first 6 years  
  McCarty, C.A., Peissig, P., Caldwell, M.D., Wilke, R.A, Personalized Medicine, 1/1/2008
• Necrotizing fasciitis due to a methicillin-sensitive Staphylococcus aureus harboring an enterotoxin gene cluster.  
  Morgan, W., Caldwell, M.D., Brady, J.M., Stemper, M.E., Reed, K.D., Shukla, S.K., Journal Clinical Microbiology, 1/1/2007
• Evaluation of genetic factors for warfarin dose prediction.  
  Caldwell, M.D., Berg, R.L., Zhang,K.Q., Glurich, I.E., Schmelzer, J.R., Yale, S.H., Vidaillet, H.J., Burmester, J.K., Clinical Medicine and Research, 1/1/2007
• Mactinin treatment promotes wound healing associated inflammation in urokinase knockout mice  
  Luikart SD, Levay-Young B, Hinkel T, Shearer JD, Mills C, Caldwell MD, Gyetko MR, Oegema TR, Wound Repair and Regeneration, 1/1/2006
• Join now to see all

Books/Book Chapters

• Principles of Pharmacogenetics and Pharmacogenomics 
  Chapter: Introduction to Population Diversity and Genetic Testing 
  Page 3 - 11Caldwell MD, Glurich I, Pillsbury K, Burmester JKEditors: Altman RB, Flockhart D and Goldstein DB.Cambridge University Press2012
• Principles of Pharmacogenetics and Pharmacogenomics. 
  Chapter: Introduction to Population Diversity and Genetic Testing. 
  Page 3 - 11Caldwell, MD, Glurich, I, Pillsbury, K, Burmester, JKEditors: Altman, R.B., Flockhart, D., and Goldstein, D.B..Cambridge University Press2012
• Wounds and Wound Management : Surgical Clinics of North America Series 
  Editors: Caldwell, MD (Guest Ed.), Martin, RF (Consulting Editor).W.B. Saunders, Co., Philadelphia, PA2010
• Wounds and Wound Management : Surgical Clinics of North America Series 
  Chapter: Wound Surgery 
  Page 1125 - 1132Caldwell MDEditors: Caldwell MD (Guest Ed.), Martin RF (Consulting Editor).W.B. Saunders, Co., Philadelphia, PA2010
• Surgical Clinics of North America Series 
  Chapter: Wounds and Wound Management 
  Page 1125 - 1132Caldwell, MDEditors: Caldwell, MD (Guest Ed); RF Martin, Consulting Editor..W.B. Saunders, Co., W.B. Saunders, Co.2010
• Cardiovascular Genetics and Genomics. AHA Publication 
  Chapter: Case Study: Warfarin Pharmacogenetics from Single to Multiple Genes 
  Caldwell MD, Berg REditors: Roden D.2009
• Cardiovascular Genetics and Genomics 
  Chapter: Case Study: Warfarin Pharmacogenetics from Single to Multiple Genes. 
  Caldwell, MD, Berg, REditors: Roden, D.AHA Publication2009
• Modern Surgical Care: Physiologic Foundations & Clinical Applications 
  Chapter: The metabolic response to starvation, stress and sepsis 
  Page 1 - 36Amaral JR, Caldwell MDEditors: Miller TA.Quality Medical Publishing, Inc., St. Louis, MOEdition 2nd,1998
• Modern Surgical Care: Physiologic Foundations & Clinical Applications, 
  Chapter: The metabolic response to starvation, stress and sepsis 
  Page 1 - 36Amaral JR, Caldwell MDEditors: Miller TA.Quality Medical Publishing, Inc., St. LouisEdition 2nd ,1998
• Growth Factors and Wound Healing 
  Chapter: Endogenous growth factors and nutrients in the healing wound 
  Page 186 - 205Arlein W, Caldwell MDEditors: Ziegler TR, Pierce GF, Herndon DN.Springer Verlag, NY1997
• Growth Factors and Wound Healing 
  Chapter: Steroid impaired wound healing: mechanisms for the beneficial effects of retinoic acid 
  Page 92 - 103Ulland AE, Shearer JD, Caldwell MDEditors: Ziegler TR, Pierce GF, Herndon DN.Springer Verlag, NY1997
• Growth Factors and Wound Healing. 
  Chapter: Endogenous growth factors and nutrients in the healing wound 
  Page 186 - 205Arlein W, Caldwell MDEditors: Ziegler TR, Pierce GF, Herndon DN.Springer Verlag, New York1997
• Growth Factors and Wound Healing. 
  Chapter: Steroid impaired wound healing: mechanisms for the beneficial effects of retinoic acid 
  Page 92 - 103Ulland AE, Shearer JD, Caldwell MDEditors: Ziegler TR, Pierce GF, Herndon DN.Springer Verlag, New York1997
• Nutrition for the Hospitalized Patient: Basic Science and Principles of Practice 
  Chapter: Lipid metablism 
  Page 37 - 55Ulland AE, Caldwell MDEditors: Torosian MH.Marcel Dekker, Inc., NY1995
• Nutrition for the Hospitalized Patient: Basic Science and Principles of Practice. 
  Chapter: Lipid metablism 
  Page 37 - 55Ulland AE, Caldwell MDEditors: Torosian, MH.Marcel Dekker, Inc., New York1995
• Clinical Nutrition II: Parenteral Nutrition 
  Editors: Rombeau J, Caldwell MD.W.B. Saunders, Co., Philadelphia, PAEdition 2nd,1993
• Clinical Nutrition 11: Parenteral Nutrition. 
  Chapter: Nutrition and Molecular Biology 
  Page 203 - 208Gartner MH, Caldwell MDEditors: Rombeau JL, Caldwell MD.W.B. Saunders Company, PhiladelphiaEdition Seco,1993
• Biology of Nitric Oxide 
  Chapter: Macrophage arginine metabolism via synthase or arginase equates with immunosurveillance or immunostimulation of cancer 
  Page 228 - 234Mills CD, Shearer J, Caldwell MDEditors: Monkadas M, Marletta MA, Hibbs JB.Portland Press, London1993
• Current Surgical Therapy 
  Chapter: Nutritional support in the surgical patient 
  Page 946 - 950Caldwell MDEditors: Cameron JL.Mosby Year Book, St. LouisEdition 4th ,1992
• Fetal Wound Healing 
  Chapter: Metabolic aspects of fetal wound healing 
  Page 241 - 253Ahrendt MN, Caldwell MDEditors: Adzick NS, Longacker M.Elsevier, New York1992
• Clinical and Experimental Approaches to Dermal & Epidermal Repair: Normal and Chronic Wounds 
  Editors: Barbul A, Pines E, Caldwell M, Hunt T, Eaglstein W.Wiley Liss, Inc., NY1991
• Clinical and Experimental Approaches to Dermal & Epidermal Repair: Normal and Chronic Wounds 
  Chapter: The temporal changes in amino acid concentration within wound fluid: A putative rationale 
  Page 205 - 222Caldwell MD, Mastrofrancesco B, Shearer JD, Bereiter DFEditors: Barbul A, Pines E, Caldwell M, Hunt T, Eaglstein W.Wiley Liss, Inc., New York1991
• Clinical and Experimental Approaches to Dermal and Experimental Repair: Normal and Chronic Wounds 
  Chapter: Concomitant macrophage activation and fibroblast/lymphocyte inhibition by wound fluid: The "arginine deficiency of inflammation" is a partial explanation 
  Page 193 - 203Mills CD, Pricolo VE, Caldwell MDEditors: Barbul AA, Pine E, Caldwell MD, Eaglestein W.Wiley Liss, Inc.1991
• Clinical Nutrition I: Enteral and Tube Feeding 
  Editors: Rombeau J, Caldwell MD.W.B. Saunders, Co., Philadelphia, PAEdition 2nd,1990
• Nitric Oxide from L Arginine: A bioregulatory system 
  Chapter: Alterations in macrophage physiology associated with the metabolism of L arginine through the oxidative L arginine deiminase pathway 
  Page 243 - 248Albina JE, Mills CD, Caldwell MDEditors: Moncada S, Higgs EA.Elsevier Science Publishers B.V.1990
• Join now to see all

Abstracts/Posters

• Treadmill exercise assessment of limb venous functional responses
  Hirsch AT, Lunzer MM, Serfass RC, Caldwell MD, Dietz CA, 10th Annual Meeting of the American Venous Forum, Lake Buena Vista, FL, 2/19/1998
• Treadmill exercise assessment of limb venous functional responses.
  Hirsch AT, Lunzer MM, Serfass RC, Caldwell MD, Dietz CA, 10th Annual Meeting of the American Venous Forum, Lake Buena Vista, FL, 2/19/1998
• Differential degradation of insulin and insulin-like growth factor I in wound fluid
  Shearer JD, Glanzer T, Coulter CF, Caldwell MD, Faseb J, 1/1/1998
• Differential degradation of insulin and insulin-like growth factor I in wound fluid.
  Shearer JD, Glanzer T, Coulter CF, Caldwell MD, Faseb, 1/1/1998
• An absence of wound insulin degradation parallels impaired wound healing in CM INH treated, steroid treated and diabetic rats.
  Coulter CF, Shearer JD, Caldwell MD, J of Minn Acad Sci, 1/1/1997
• An absence of wound insulin degradation parallels impaired wound healing in CM INH treated, steroid treated and diabetic rats
  Coulter CF, Shearer JD, Caldwell MD, J of Minn Acad Sci, 1/1/1997
• Insulin degrading activity in normal diabetic and insulin treated diabetic rats.
  Shearer JD, Coulter CF, Caldwell MD, Wound Repair and Regeneration, 1/1/1996
• Insulin degrading activity in normal diabetic and insulin treated diabetic rats
  Shearer JD, Coulter CF, Caldwell MD, Wound Repair and Regeneration, 1/1/1996
• Characterization of insulin degrading activity in normal healing wounds
  Coulter CF, Shearer JD, Caldwell MD, Faseb J, 1/1/1996
• Differential degradation of peptide hormones and growth factors in wounds
  Shearer JD, Coulter CF, Caldwell MD, Faseb J, 1/1/1996
• Stimulatory and inhibitory effects of wound fluid (WF) on fibroblast proliferation
  Wotus C, Shearer JD, Caldwell MD, Faseb J, 1/1/1996
• Characterization of insulin degrading activity in normal healing wounds.
  Coulter CF, Shearer JD, Caldwell MD, Faseb, 1/1/1996
• Differential degradation of peptide hormones and growth factors in wounds.
  Shearer JD, Coulter CF, Caldwell MD, Faseb, 1/1/1996
• Stimulatory and inhibitory effects of wound fluid (WF) on fibroblast proliferation.
  Wotus C, Shearer JD, Caldwell MD, Faseb, 1/1/1996
• Investigation of rat fibroblast replication using PKE 2, a fluorescent label.
  Arlein WJ, Shearer JD, Caldwell MD, Wound Repair and Regeneration, 1/1/1995
• Flow cytometric analysis of wound cell replication.
  Shearer JD, Aberle LA, Richards JR, Caldwell MD, Wound Repair and Regeneration, 1/1/1995
• Retinoic acid reverses steroid impaired arginase activity in rat wounds.
  Ulland AE, Shearer JD, Caldwell MD, Wound Repair and Regeneration, 1/1/1995
• Investigation of rat fibroblast replication using PKE 2, a fluorescent label
  Arlein WJ, Shearer JD, Caldwell MD, Wound Repair and Regeneration, 1/1/1995
• Flow cytometric analysis of wound cell replication
  Shearer JD, Aberle LA, Richards JR, Caldwell MD, Wound Repair and Regeneration, 1/1/1995
• Retinoic acid reverses steroid impaired arginase activity in rat wounds
  Ulland AE, Shearer JD, Caldwell MD, Wound Repair and Regeneration, 1/1/1995
• The role of 15 deoxyspergualin (DSG) in the prevention of diabetes in the BBIW rat
  Lokeh A, Stevens RB, Ansite JD, Benson J, Tepper M, Caldwell MD, Brayman KL, Sutherland DER, Transplant Proceedings, 4/1/1994
• The role of nitric oxide (NO) in the pathogenesis of early pancreatic islet (lx) dysfunction during rat and human intraportal (IP) islet transplantation (Tx)
  Stevens RB, Ansite JD, Lokeh A, Benson J, Field MJ, Caldwell MD, Gores PF, Sutherland DER, Transplant Proceedings, 4/1/1994
• The role of 15 deoxyspergualin (DSG) in the prevention of diabetes in the BBIW rat.
  Lokeh A, Stevens RB, Ansite JD, Benson J, Tepper M, Caldwell MD, Brayman KL, Sutherland DER, Transplant Proceedings, 4/1/1994
• The role of nitric oxide (NO) in the pathogenesis of early pancreatic islet (lx) dysfunction during rat and human intraportal (IP) islet transplantation (Tx).
  Stevens RB, Ansite JD, Lokeh A, Benson J, Field MJ, Caldwell MD, Gores PF, Sutherland DER, Transplant Proceedings, 4/1/1994
• Altered arginine metabolism in diabetic wounds.
  Shearer JD, Caldwell MD, Wound Repair and Regeneration, 1/1/1994
• Join now to see all

Lectures

• Mediators of Inflammation from Physiologic Basis of Surgery by O'Leary 
  Marshfield, WI - 2/24/2012
• Surgical Infection from Physiologic Basis of Surgery by O'Leary. 
  Marshfield, WI - 1/17/2012
• Surgical Infection from Physiologic Basis of Surgery by O'Leary 
  Marshfield, WI - 1/17/2012
• Wound Healing from Physiologic Basis of Surgery by O'Leary. 
  Marshfield, WI - 3/15/2011
• Wound Healing, Surgical Residents Basic Science Lectures 
  Marshfield, WI - 3/15/2011
• Wound Healing from Physiologic Basis of Surgery by O'Leary 
  Marshfield, WI - 3/15/2011
• Wound Healing 
  St. Joseph’s Hospital, Marshfield, WI - 3/15/2011
• Pharmacogenetic Approaches to Warfarin Dosing 
  Washington, DC - 1/6/2011
• Cows, and Enzymes, and Rats ! Oh My ! 
  Marshfield Clinic, Marshfield, WI - 5/18/2010
• Cows, and Enzymes, and Rats! Oh My! 
  Marshfield, WI - 5/18/2010
• Pharmacogenetics of Warfarin 
  Chicago, IL - 7/22/2009
• Warfarin Pharmacogenetics 
  Appleton, WI - 4/28/2009
• Warfarin Pharmacogenetics Wisconsin 
  Appleton, WI - 4/28/2009
• Candidate Gene Approach to Warfarin Dosing. 
  Rockville, MD - 11/4/2008
• Candidate Gene Approach to Warfarin Dosing 
  Rockville, MD - 11/4/2008
• Novel Genotypes Associated with Warfarin Stable Therapeutic Dose and the IWPC 
  FDA Bethesda, MD - 11/3/2008
• The Marshfield Clinic Prospective Genotyping for Warfarin Dosing Experience. 
  FDA Bethesda, MD - 11/3/2008
• The Marshfield Clinic Prospective Genotyping for Warfarin Dosing Experience 
  Bethesda, MD - 11/3/2008
• Genetic Loci Responsible for Interindividual Differences in Response to Warfarin 
  American Regional ISSX Meeting - 10/15/2008
• Using Warfarin Pharmacogenetics to Design New Anticoagulants 
  UW-Stout, Menomonie, WI - 7/18/2008
• Genotyping for Warfarin Dosing (Invited Presentation ) 
  Philadelphia, PA - 9/17/2007
• Genotyping for Warfarin Dosing (Invited Presentation) 
  Philadelphia, PA - 9/17/2007
• Making Personalized Predictive Medicine A Bedside Reality (Invited Presentation) 
  Washington, DC - 9/11/2007
• Recent Developments in Warfarin Pharmacogenetics (Invited Seminar) 
  Stanford University, Palo Alto, CA - 6/7/2007
• Recent Developments in Warfarin Pharmacogenetics (Invited Seminar) 
  Palo Alto, CA - 6/7/2007
• Join now to see all

Other

• Nutrition Care Delivery: Dynamics and Economics 
  Caldwell MD, National Video Teleconference
  Providence, RI - 10/26/1983